|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07H 19/173 | |
| A61K 31/7076 | |||
| C07H 19/207 | |||
| A61P 35/00 | |||
| A61P 35/02 |
| (11) | Patento numeris | 3464309 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17728596.2 |
| Europos patento paraiškos padavimo data | 2017-05-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-04-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-06-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2017/051549 |
| Data | 2017-05-31 |
| (87) | Numeris | WO 2017/207986 |
| Data | 2017-12-07 |
| (30) | Numeris | Data | Šalis |
| 201609601 | 2016-06-01 | GB |
| (72) |
GRIFFITH, Hugh, GB
SERPI, Michaela, GB
SLUSARCZYK, Magdalena, GB
|
| (73) |
NuCana plc,
3 Lochside Way, Edinburgh EH12 9DT,
GB
|
| (54) | PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS |
| PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS |